132 related articles for article (PubMed ID: 27089454)
1. Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations.
Tholen S; Wolf C; Mayer B; Knopf JD; Löffek S; Qian Y; Kizhakkedathu JN; Biniossek ML; Franzke CW; Schilling O
J Proteome Res; 2016 May; 15(5):1402-17. PubMed ID: 27089454
[TBL] [Abstract][Full Text] [Related]
2. ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C γ1 and protein kinase C pathways.
Wolf C; Qian Y; Brooke MA; Kelsell DP; Franzke CW
Sci Rep; 2016 Dec; 6():39780. PubMed ID: 28004780
[TBL] [Abstract][Full Text] [Related]
3. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
[TBL] [Abstract][Full Text] [Related]
5. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17.
Liu J; Zhu G; Jia N; Wang W; Wang Y; Yin M; Jiang X; Huang Y; Zhang J
Int J Biol Sci; 2019; 15(2):493-506. PubMed ID: 30745837
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase 10 Degradomics in Keratinocytes and Epidermal Tissue Identifies Bioactive Substrates With Pleiotropic Functions.
Schlage P; Kockmann T; Sabino F; Kizhakkedathu JN; Auf dem Keller U
Mol Cell Proteomics; 2015 Dec; 14(12):3234-46. PubMed ID: 26475864
[TBL] [Abstract][Full Text] [Related]
7. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function.
Joly-Tonetti N; Ondet T; Monshouwer M; Stamatas GN
BMC Cancer; 2021 Jan; 21(1):5. PubMed ID: 33402117
[TBL] [Abstract][Full Text] [Related]
8. A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.
Shipman WD; Chyou S; Ramanathan A; Izmirly PM; Sharma S; Pannellini T; Dasoveanu DC; Qing X; Magro CM; Granstein RD; Lowes MA; Pamer EG; Kaplan DH; Salmon JE; Mehrara BJ; Young JW; Clancy RM; Blobel CP; Lu TT
Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111646
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH
Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447
[TBL] [Abstract][Full Text] [Related]
10. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
[TBL] [Abstract][Full Text] [Related]
11. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
[TBL] [Abstract][Full Text] [Related]
12. ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer.
Mustafi R; Dougherty U; Mustafi D; Ayaloglu-Butun F; Fletcher M; Adhikari S; Sadiq F; Meckel K; Haider HI; Khalil A; Pekow J; Konda V; Joseph L; Hart J; Fichera A; Li YC; Bissonnette M
Clin Cancer Res; 2017 Jan; 23(2):549-561. PubMed ID: 27489286
[TBL] [Abstract][Full Text] [Related]
13. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
[TBL] [Abstract][Full Text] [Related]
14. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
[TBL] [Abstract][Full Text] [Related]
16. The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa.
Rademacher F; Simanski M; Schröder L; Mildner M; Harder J
Exp Dermatol; 2017 Mar; 26(3):227-233. PubMed ID: 27513608
[TBL] [Abstract][Full Text] [Related]
17. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R
Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418
[TBL] [Abstract][Full Text] [Related]
18. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
Sahin U; Blobel CP
FEBS Lett; 2007 Jan; 581(1):41-4. PubMed ID: 17169360
[TBL] [Abstract][Full Text] [Related]
19. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
[TBL] [Abstract][Full Text] [Related]
20. The shedding protease ADAM17: Physiology and pathophysiology.
Zunke F; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
